vs

Side-by-side financial comparison of Corpay (CPAY) and Organon & Co. (OGN). Click either name above to swap in a different company.

Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.2B, roughly 1.2× Corpay). Corpay runs the higher net margin — 21.2% vs -13.6%, a 34.8% gap on every dollar of revenue. On growth, Corpay posted the faster year-over-year revenue change (20.7% vs -5.3%). Corpay produced more free cash flow last quarter ($760.3M vs $96.0M). Over the past eight quarters, Corpay's revenue compounded faster (15.5% CAGR vs -3.6%).

Corpay, Inc., headquartered in Atlanta, Georgia, provides payments and spend management systems and services that control expense-related purchasing and payment processes. The company focuses on vehicle-related expenses, lodging expenses, and corporate payments.

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

CPAY vs OGN — Head-to-Head

Bigger by revenue
OGN
OGN
1.2× larger
OGN
$1.5B
$1.2B
CPAY
Growing faster (revenue YoY)
CPAY
CPAY
+26.0% gap
CPAY
20.7%
-5.3%
OGN
Higher net margin
CPAY
CPAY
34.8% more per $
CPAY
21.2%
-13.6%
OGN
More free cash flow
CPAY
CPAY
$664.3M more FCF
CPAY
$760.3M
$96.0M
OGN
Faster 2-yr revenue CAGR
CPAY
CPAY
Annualised
CPAY
15.5%
-3.6%
OGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CPAY
CPAY
OGN
OGN
Revenue
$1.2B
$1.5B
Net Profit
$264.5M
$-205.0M
Gross Margin
49.2%
Operating Margin
45.2%
-9.8%
Net Margin
21.2%
-13.6%
Revenue YoY
20.7%
-5.3%
Net Profit YoY
7.5%
-288.1%
EPS (diluted)
$3.74
$-0.78

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPAY
CPAY
OGN
OGN
Q4 25
$1.2B
$1.5B
Q3 25
$1.2B
$1.6B
Q2 25
$1.1B
$1.6B
Q1 25
$1.0B
$1.5B
Q4 24
$1.0B
$1.6B
Q3 24
$1.0B
$1.6B
Q2 24
$975.7M
$1.6B
Q1 24
$935.3M
$1.6B
Net Profit
CPAY
CPAY
OGN
OGN
Q4 25
$264.5M
$-205.0M
Q3 25
$277.9M
$160.0M
Q2 25
$284.2M
$145.0M
Q1 25
$243.2M
$87.0M
Q4 24
$246.0M
$109.0M
Q3 24
$276.4M
$359.0M
Q2 24
$251.6M
$195.0M
Q1 24
$229.8M
$201.0M
Gross Margin
CPAY
CPAY
OGN
OGN
Q4 25
49.2%
Q3 25
53.5%
Q2 25
54.8%
Q1 25
55.6%
Q4 24
56.3%
Q3 24
58.3%
Q2 24
58.4%
Q1 24
59.0%
Operating Margin
CPAY
CPAY
OGN
OGN
Q4 25
45.2%
-9.8%
Q3 25
44.6%
15.2%
Q2 25
43.5%
14.4%
Q1 25
42.5%
6.7%
Q4 24
47.2%
8.1%
Q3 24
45.5%
13.1%
Q2 24
44.4%
14.6%
Q1 24
42.5%
14.5%
Net Margin
CPAY
CPAY
OGN
OGN
Q4 25
21.2%
-13.6%
Q3 25
23.7%
10.0%
Q2 25
25.8%
9.1%
Q1 25
24.2%
5.8%
Q4 24
23.8%
6.8%
Q3 24
26.9%
22.7%
Q2 24
25.8%
12.1%
Q1 24
24.6%
12.4%
EPS (diluted)
CPAY
CPAY
OGN
OGN
Q4 25
$3.74
$-0.78
Q3 25
$3.91
$0.61
Q2 25
$3.98
$0.56
Q1 25
$3.40
$0.33
Q4 24
$3.43
$0.42
Q3 24
$3.90
$1.38
Q2 24
$3.52
$0.75
Q1 24
$3.12
$0.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPAY
CPAY
OGN
OGN
Cash + ST InvestmentsLiquidity on hand
$2.4B
$574.0M
Total DebtLower is stronger
$10.0B
$8.6B
Stockholders' EquityBook value
$3.9B
$752.0M
Total Assets
$26.4B
$12.9B
Debt / EquityLower = less leverage
2.58×
11.49×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPAY
CPAY
OGN
OGN
Q4 25
$2.4B
$574.0M
Q3 25
$2.0B
$672.0M
Q2 25
$2.2B
$599.0M
Q1 25
$1.6B
$547.0M
Q4 24
$1.6B
$675.0M
Q3 24
$1.3B
$763.0M
Q2 24
$1.4B
$704.0M
Q1 24
$1.3B
$575.0M
Total Debt
CPAY
CPAY
OGN
OGN
Q4 25
$10.0B
$8.6B
Q3 25
$8.1B
$8.8B
Q2 25
$8.1B
$8.9B
Q1 25
$8.2B
$9.0B
Q4 24
$8.0B
$8.9B
Q3 24
$8.7B
Q2 24
$8.7B
Q1 24
$8.7B
Stockholders' Equity
CPAY
CPAY
OGN
OGN
Q4 25
$3.9B
$752.0M
Q3 25
$4.1B
$906.0M
Q2 25
$3.9B
$733.0M
Q1 25
$3.5B
$542.0M
Q4 24
$3.1B
$472.0M
Q3 24
$3.1B
$493.0M
Q2 24
$2.8B
$144.0M
Q1 24
$3.3B
$48.0M
Total Assets
CPAY
CPAY
OGN
OGN
Q4 25
$26.4B
$12.9B
Q3 25
$19.7B
$13.6B
Q2 25
$20.4B
$13.5B
Q1 25
$18.5B
$13.2B
Q4 24
$18.0B
$13.1B
Q3 24
$17.6B
$12.8B
Q2 24
$16.2B
$12.2B
Q1 24
$15.8B
$11.9B
Debt / Equity
CPAY
CPAY
OGN
OGN
Q4 25
2.58×
11.49×
Q3 25
1.99×
9.74×
Q2 25
2.07×
12.14×
Q1 25
2.37×
16.52×
Q4 24
2.56×
18.81×
Q3 24
17.75×
Q2 24
60.11×
Q1 24
181.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPAY
CPAY
OGN
OGN
Operating Cash FlowLast quarter
$812.7M
$141.0M
Free Cash FlowOCF − Capex
$760.3M
$96.0M
FCF MarginFCF / Revenue
60.9%
6.4%
Capex IntensityCapex / Revenue
4.2%
3.0%
Cash ConversionOCF / Net Profit
3.07×
TTM Free Cash FlowTrailing 4 quarters
$1.3B
$538.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPAY
CPAY
OGN
OGN
Q4 25
$812.7M
$141.0M
Q3 25
$-378.9M
$264.0M
Q2 25
$1.1B
$220.0M
Q1 25
$-74.2M
$75.0M
Q4 24
$648.7M
$390.0M
Q3 24
$400.8M
$141.0M
Q2 24
$540.9M
$332.0M
Q1 24
$350.2M
$76.0M
Free Cash Flow
CPAY
CPAY
OGN
OGN
Q4 25
$760.3M
$96.0M
Q3 25
$-429.8M
$218.0M
Q2 25
$1.1B
$181.0M
Q1 25
$-118.9M
$43.0M
Q4 24
$604.6M
$335.0M
Q3 24
$355.0M
$99.0M
Q2 24
$496.8M
$300.0M
Q1 24
$309.0M
$30.0M
FCF Margin
CPAY
CPAY
OGN
OGN
Q4 25
60.9%
6.4%
Q3 25
-36.7%
13.6%
Q2 25
98.7%
11.4%
Q1 25
-11.8%
2.8%
Q4 24
58.4%
21.0%
Q3 24
34.5%
6.3%
Q2 24
50.9%
18.7%
Q1 24
33.0%
1.8%
Capex Intensity
CPAY
CPAY
OGN
OGN
Q4 25
4.2%
3.0%
Q3 25
4.3%
2.9%
Q2 25
4.8%
2.4%
Q1 25
4.5%
2.1%
Q4 24
4.3%
3.5%
Q3 24
4.4%
2.7%
Q2 24
4.5%
2.0%
Q1 24
4.4%
2.8%
Cash Conversion
CPAY
CPAY
OGN
OGN
Q4 25
3.07×
Q3 25
-1.36×
1.65×
Q2 25
4.01×
1.52×
Q1 25
-0.30×
0.86×
Q4 24
2.64×
3.58×
Q3 24
1.45×
0.39×
Q2 24
2.15×
1.70×
Q1 24
1.52×
0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPAY
CPAY

Vehicle Payments$572.9M46%
Corporate Payments$480.8M39%
Lodging Payments$112.5M9%
Other Operating Segments$82.1M7%

OGN
OGN

Segment breakdown not available.

Related Comparisons